Kidney study tests drug safety in 50 volunteers
NCT ID NCT07154901
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study looks at how the drug opemalirsen behaves in people with different levels of kidney function. About 50 adults aged 18 to 80 will receive a single dose, and researchers will measure drug levels in the blood. The goal is to understand safety and dosing, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGMiami, Florida, 33172, United States
-
Research Site
RECRUITINGOrlando, Florida, 32808, United States
Conditions
Explore the condition pages connected to this study.